Immix Biopharma Inc’s latest rating changes from various analysts
Immix Biopharma Inc’s filing revealed that its Director Hsu Jason acquired Company’s shares for reported $0.14 million on Dec 11 ’23. In the deal valued at $4.67 per share,31,000 shares were bought. As a result of this transaction, Hsu Jason now holds 813,000 shares worth roughly $2.09 million. Then, Hsu Jason bought 25,000 shares, generating […]
Immix Biopharma Inc’s latest rating changes from various analysts
Immix Biopharma Inc’s filing revealed that its Director Hsu Jason acquired Company’s shares for reported $0.14 million on Dec 11 ’23. In the deal valued at $4.67 per share,31,000 shares were bought. As a result of this transaction, Hsu Jason now holds 813,000 shares worth roughly $2.31 million. Then, Hsu Jason bought 25,000 shares, generating […]
